Creatine and Resistance Training: What the Evidence Says

Quick Answer

Creatine and Resistance Training has 5 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 3 systematic review, 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• These studies have been removed, and the affected PRISMA flow diagram, study-characteristics table, risk-of-bias summary, outcome analyses, subgroup analyses, GRADE table, figures, and supplementary files have been updated accordingly. [Gu Jinfa (2026); evidence level 1]
• Theandsections of the abstract have been corrected to read: This systematic review and meta-analysis pooled RCT evidence in healthy men aged 18-30 years old to quantify the effects of creatine supplementation in terms of body composition, maximal strength, and exercise performance. [Gu Jinfa (2026); evidence level 1]
• The scientific community has responded with growing scrutiny of extraordinary health and weight-loss promises that lack robust evidence, reinforcing the need for critical appraisal and public clarification regarding risks and benefits. [Gimenez Fabiana V. M. (2026); evidence level 1]
• Despite strong evidence supporting its ergogenic effects, misconceptions persist, including beliefs that creatine causes excessive water retention, kidney damage, baldness, muscle cramping, dehydration, steroid-like effects, or fat gain. [Gimenez Fabiana V. M. (2026); evidence level 1]
• Creatine is an inborn nitrogen-containing compound, of which approximately 95% is present in the skeletal muscle; smaller quantities are found in tissues such as the brain, myocardium, and testes. [Gu Jinfa (2026); evidence level 1]
• Several systematic reviews and meta-analyses have found modest increases in lean body mass or fat-free mass; however, some have also found large between-study variability. [Gu Jinfa (2026); evidence level 1]
• The importance of the timing of Cr administration is based on the assumption that exercise-induced physiological changes, such as increased hyperemia and altered transport dynamics, may optimize tissue absorption and storage. [Ben Maaoui Khouloud (2026); evidence level 2]
• Yet, evidence supporting specific timing strategies is restricted to a few chronic studies with conflicting findings. [Ben Maaoui Khouloud (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For creatine supplementation resistance training, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Bottom Line For Readers

For creatine and resistance training, this knowledge-base sample includes at least one stronger evidence source. One representative source-reported claim is: "These studies have been removed, and the affected PRISMA flow diagram, study-characteristics table, risk-of-bias summary, outcome analyses, subgroup analyses, GRADE table, figures, and supplementary files have been updated accordingly." The safest editorial posture is to focus on resistance-training contexts, lean mass or performance outcomes, and study population details.

Evidence Strength

The current evidence set includes 5 unique source documents. 4 sources are level 1-2 in this system, while 1 source is lower-level, indirect, narrative, or early-stage evidence. Treat this as a structured reading guide rather than a final clinical guideline.

What This Means In Practice

• Tie claims to resistance training, population, and measured outcomes such as lean mass, strength, or repeated effort.
• Distinguish creatine monohydrate evidence from claims about newer or branded forms.
• Keep safety language conservative for people with kidney disease, medications, pregnancy, or adolescent use.

What The Evidence Does Not Prove

• It does not prove the same benefit for every age group, sex, training status, sport, or dose.
• It does not justify product-specific claims unless product quality and formulation evidence are separately reviewed.

Editorial Use Cases

This page is most useful as a citation hub for answer-first pages about creatine and resistance training. It can support cautious explainers, comparison sections, safety notes, and evidence tables. It should not be used alone to rank products, promise outcomes, or replace condition-specific clinical guidance.

Limits Of This First Pass

This deep evidence page is still generated from a bounded knowledge-base sample. It should be reviewed by a human editor before being used for high-stakes decisions or product-ranking claims.

References

• Gu Jinfa (2026). Correction: Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass. DOI: 10.3389/fnut.2026.1854605. PMCID: PMC13231500. PMID: 42245548. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13231500/
• Gimenez Fabiana V. M. (2026). Does creatine affect lipid profile? a systematic review and meta-analysis of randomized placebo-controlled trials. DOI: 10.3389/fnut.2026.1787009. PMCID: PMC13194357. PMID: 42180567. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13194357/
• Gu Jinfa (2026). Creatine supplementation in young men under resistance versus non-resistance training: a systematic review and meta-analysis of strength, performance, and lean mass. DOI: 10.3389/fnut.2026.1800546. PMCID: PMC13099317. PMID: 42027564. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13099317/
• Ben Maaoui Khouloud (2026). Acute Creatine Ingestion Before Resistance Training Enhances Strength Performance More than Ingestion During or After Training: A Randomized Crossover Pilot Trial. DOI: 10.3390/nu18111789. PMCID: PMC13258838. PMID: 42280432. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258838/
• Kerksick Chad (2026). The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications. DOI: 10.1080/15502783.2026.2646627. PMCID: PMC13011109. PMID: 41870601. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13011109/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.